ロード中...

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer. The prognostic signature could be reliable to stratify LUAD patients according to risk, which helps the management of the systematic treatments. In this study, a systematic and reliable immune signature was performed...

詳細記述

保存先:
書誌詳細
出版年:J Transl Med
主要な著者: Guo, Dina, Wang, Mian, Shen, Zhihong, Zhu, Jiaona
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060601/
https://ncbi.nlm.nih.gov/pubmed/32143735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02286-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!